PCM
KRTX
Pentwater Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-1,066,200
| Closed | -$337M | – | 93 |
|
2023
Q4 | $337M | Buy |
1,066,200
+1,037,700
| +3,641% | +$328M | 3.78% | 5 |
|
2023
Q3 | $4.82M | Buy |
28,500
+1,500
| +6% | +$254K | 0.03% | 40 |
|
2023
Q2 | $5.85M | Sell |
27,000
-21,000
| -44% | -$4.55M | 0.04% | 46 |
|
2023
Q1 | $8.72M | Buy |
48,000
+38,000
| +380% | +$6.9M | 0.08% | 46 |
|
2022
Q4 | $1.97M | Buy |
10,000
+3,500
| +54% | +$688K | 0.03% | 53 |
|
2022
Q3 | $1.46M | Sell |
6,500
-23,500
| -78% | -$5.29M | 0.02% | 79 |
|
2022
Q2 | $3.8M | Sell |
30,000
-10,000
| -25% | -$1.27M | 0.04% | 69 |
|
2022
Q1 | $5.07M | Sell |
40,000
-20,000
| -33% | -$2.54M | 0.06% | 55 |
|
2021
Q4 | $7.86M | Sell |
60,000
-8,200
| -12% | -$1.07M | 0.09% | 49 |
|
2021
Q3 | $8.34M | Hold |
68,200
| – | – | 0.08% | 58 |
|
2021
Q2 | $7.77M | Hold |
68,200
| – | – | 0.06% | 58 |
|
2021
Q1 | $8.2M | Buy |
68,200
+8,200
| +14% | +$986K | 0.08% | 62 |
|
2020
Q4 | $6.1M | Sell |
60,000
-10,000
| -14% | -$1.02M | 0.07% | 50 |
|
2020
Q3 | $5.41M | Buy |
70,000
+23,000
| +49% | +$1.78M | 0.07% | 60 |
|
2020
Q2 | $5.24M | Sell |
47,000
-9,417
| -17% | -$1.05M | 0.09% | 37 |
|
2020
Q1 | $4.06M | Sell |
56,417
-1,534
| -3% | -$110K | 0.07% | 41 |
|
2019
Q4 | $4.37M | Sell |
57,951
-4,499
| -7% | -$339K | 0.07% | 42 |
|
2019
Q3 | $1.02M | Sell |
62,450
-7,550
| -11% | -$123K | 0.02% | 67 |
|
2019
Q2 | $1.4M | Buy |
+70,000
| New | +$1.4M | 0.02% | 72 |
|